ES547019A0 - Un procedimiento para la preparacion de un reactivo de inmunoensayo. - Google Patents

Un procedimiento para la preparacion de un reactivo de inmunoensayo.

Info

Publication number
ES547019A0
ES547019A0 ES547019A ES547019A ES547019A0 ES 547019 A0 ES547019 A0 ES 547019A0 ES 547019 A ES547019 A ES 547019A ES 547019 A ES547019 A ES 547019A ES 547019 A0 ES547019 A0 ES 547019A0
Authority
ES
Spain
Prior art keywords
procedure
preparation
assay reagent
immuno assay
immuno
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES547019A
Other languages
English (en)
Other versions
ES8705634A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of ES547019A0 publication Critical patent/ES547019A0/es
Publication of ES8705634A1 publication Critical patent/ES8705634A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
    • C07F15/0046—Ruthenium compounds
    • C07F15/0053—Ruthenium compounds without a metal-carbon linkage
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G01N33/532—Production of labelled immunochemicals
    • G01N33/533—Production of labelled immunochemicals with fluorescent label
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/80—Fluorescent dyes, e.g. rhodamine

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Food Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
ES547019A 1984-09-17 1985-09-16 Un procedimiento para la preparacion de un reactivo de inmunoensayo. Expired ES8705634A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH443384 1984-09-17
CH298485 1985-07-10

Publications (2)

Publication Number Publication Date
ES547019A0 true ES547019A0 (es) 1987-05-01
ES8705634A1 ES8705634A1 (es) 1987-05-01

Family

ID=25691887

Family Applications (1)

Application Number Title Priority Date Filing Date
ES547019A Expired ES8705634A1 (es) 1984-09-17 1985-09-16 Un procedimiento para la preparacion de un reactivo de inmunoensayo.

Country Status (10)

Country Link
US (1) US4745076A (es)
EP (1) EP0178450B1 (es)
JP (1) JPH0690201B2 (es)
AU (1) AU586831B2 (es)
CA (1) CA1261744A (es)
DE (1) DE3582549D1 (es)
DK (1) DK365785A (es)
ES (1) ES8705634A1 (es)
NO (1) NO163694C (es)
NZ (1) NZ213420A (es)

Families Citing this family (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5238808A (en) * 1984-10-31 1993-08-24 Igen, Inc. Luminescent metal chelate labels and means for detection
US5221605A (en) * 1984-10-31 1993-06-22 Igen, Inc. Luminescent metal chelate labels and means for detection
US5310687A (en) * 1984-10-31 1994-05-10 Igen, Inc. Luminescent metal chelate labels and means for detection
US5585279A (en) * 1986-01-23 1996-12-17 Davidson; Robert S. Time-resolved luminescence binding assays using a fluorescent transition metal label other than ruthenium
GB8601646D0 (en) * 1986-01-23 1986-02-26 Davidson R S Binding assay & reagent
US6165729A (en) * 1986-04-30 2000-12-26 Hyperion Catalysis International, Inc. Electrochemiluminescent reaction utilizing amine-derived reductant
JPH0737464B2 (ja) * 1986-04-30 1995-04-26 イゲン，インコーポレーテッド エレクトロ化学ルミネセンスアツセイ
US6881536B1 (en) * 1986-04-30 2005-04-19 Bioveris Corporation Particle based electrochemiluminescent assays
US6451225B1 (en) 1986-04-30 2002-09-17 Igen International, Inc. Electrochemiluminescent reaction utilizing amine-derived reductant
US5591581A (en) * 1986-04-30 1997-01-07 Igen, Inc. Electrochemiluminescent rhenium moieties and methods for their use
US6316607B1 (en) 1986-04-30 2001-11-13 Igen International, Inc. Electrochemiluminescent assays
US6881589B1 (en) * 1987-04-30 2005-04-19 Bioveris Corporation Electrochemiluminescent localizable complexes for assay compositions
JPH0682101B2 (ja) * 1988-03-25 1994-10-19 理化学研究所 ｐＨ測定用発光プローブ錯体及びｐＨ測定法
US6702986B1 (en) 1988-04-29 2004-03-09 Igen International, Inc. Electrochemiluminescent reaction utilizing amine-derived reductant
AU622899B2 (en) * 1988-05-04 1992-04-30 F. Hoffmann-La Roche Ag Rutheniumcomplex-compounds
ZA898290B (en) * 1988-11-03 1991-06-26 Igen Inc Electrochemiluminescent assays
US5208007A (en) * 1988-11-22 1993-05-04 Board Of Regents Of The University Of Oklahoma Isotopic tracer composition and method for making and using same
CA2033692A1 (en) * 1990-01-25 1991-07-26 Wilhelm Bannwarth Energy transfer systems
US5367080A (en) * 1990-11-08 1994-11-22 Sterling Winthrop Inc. Complexing agents and targeting radioactive immunoreagents useful in therapeutic and diagnostic imaging compositions and methods
FR2673183B1 (fr) * 1991-02-21 1996-09-27 Asulab Sa Complexes mono, bis ou tris (2,2'-bipyridine substituee) d'un metal choisi parmi le fer, le ruthenium, l'osmium ou le vanadium et leurs procedes de preparation .
ZA929351B (en) * 1991-12-11 1993-06-04 Igen Inc Electrochemiluminescent label for DNA assays.
AU672951B2 (en) * 1992-05-07 1996-10-24 Ge Healthcare As Complexing agents and targeting immunoreagents
US5958783A (en) * 1994-07-25 1999-09-28 Roche Diagnostics Gmbh Metal complexes with a charged linker
CN1114106C (zh) * 1994-07-25 2003-07-09 罗切诊断学有限公司 金属螯合物标记的肽及其制备方法
DE59511054D1 (de) * 1994-07-25 2006-08-10 Roche Diagnostics Gmbh Bestimmung von spezifischem immunglobulin unter verwendung multipler antigene
CA2195752C (en) * 1994-07-25 2010-10-26 Hans-Peter Josel Oligomeric carrier molecules with defined incorporated marker groups andhaptens
DE59507438D1 (de) * 1994-07-25 2000-01-20 Roche Diagnostics Gmbh Hydrophile metallkomplexe
US7745142B2 (en) 1997-09-15 2010-06-29 Molecular Devices Corporation Molecular modification assays
US7632651B2 (en) 1997-09-15 2009-12-15 Mds Analytical Technologies (Us) Inc. Molecular modification assays
US7070921B2 (en) 2000-04-28 2006-07-04 Molecular Devices Corporation Molecular modification assays
US6306661B1 (en) * 1998-02-05 2001-10-23 Joseph R. Lakowicz Water soluble luminescence oxygen sensor and method
DE19811582A1 (de) * 1998-03-17 1999-09-23 Roche Diagnostics Gmbh Stabilisierung und Verstärkung von Elektrochemilumineszenz-Signalen
EP0957360B1 (de) 1998-05-06 2002-07-31 Roche Diagnostics GmbH Entstörung durch Rheumafaktoren
DE19828441A1 (de) 1998-06-25 1999-12-30 Roche Diagnostics Gmbh Verwendung derivatisierter Reagenzien in Chemilumineszenz- und Elektrochemilumineszenz-Nachweisverfahren
US6410255B1 (en) * 1999-05-05 2002-06-25 Aurora Biosciences Corporation Optical probes and assays
WO2001046209A1 (en) * 1999-12-20 2001-06-28 Fluorrx, Inc. Fluorescent probes
US7198924B2 (en) * 2000-12-11 2007-04-03 Invitrogen Corporation Methods and compositions for synthesis of nucleic acid molecules using multiple recognition sites
DE10048417A1 (de) * 2000-09-29 2002-04-11 Roche Diagnostics Gmbh Verbindungen mit verzweigtem Linker
US6808939B2 (en) 2001-06-29 2004-10-26 Igen International, Inc. ECL labels having improved non-specific binding properties, methods of using and kits containing the same
US6664111B2 (en) * 2001-08-22 2003-12-16 3M Innovative Properties Company Fluorescence based oxygen sensor systems
DE10239098A1 (de) * 2002-08-26 2004-03-11 Roche Diagnostics Gmbh Erzeugung von Chemilumineszenz durch Wasserstoff
US7727752B2 (en) * 2003-07-29 2010-06-01 Life Technologies Corporation Kinase and phosphatase assays
US7619059B2 (en) * 2003-07-29 2009-11-17 Life Technologies Corporation Bimolecular optical probes
CA2445420A1 (en) * 2003-07-29 2005-01-29 Invitrogen Corporation Kinase and phosphatase assays
WO2005014796A2 (en) 2003-08-08 2005-02-17 Invitrogen Corporation Methods and compositions for seamless cloning of nucleic acid molecules
US20050064485A1 (en) * 2003-09-12 2005-03-24 Kurt Vogel Multiplex binding and activity assays
WO2005054438A2 (en) 2003-12-01 2005-06-16 Invitrogen Corporation Nucleic acid molecules containing recombination sites and methods of using the same
CN1914331A (zh) 2004-02-06 2007-02-14 拜尔健康护理有限责任公司 作为生物传感器的内部参照的可氧化种类和使用方法
US7514223B2 (en) * 2004-05-15 2009-04-07 Genentech, Inc. Cross-screening system and methods for detecting a molecule having binding affinity for a target molecule
ITTO20040372A1 (it) * 2004-06-01 2004-09-01 Giuseppe Caputo Composti luminescenti aventi un braccio di legame funzionalizzato.
JP5590796B2 (ja) 2005-06-03 2014-09-17 ボード・オブ・リージェンツ・オブ・ザ・ユニバーシティ・オブ・テキサス・システム 電気化学および単一ファラデー電極による電気化学発光
WO2007013915A1 (en) 2005-07-20 2007-02-01 Bayer Healthcare Llc Gated amperometry
WO2007040913A1 (en) 2005-09-30 2007-04-12 Bayer Healthcare Llc Gated voltammetry
ES2444695T3 (es) * 2006-06-23 2014-02-26 Alethia Biotherapeutics Inc. Polinucleótidos y polipéptidos implicados en el cáncer
IL178494A0 (en) * 2006-10-05 2007-02-11 Univ Ben Gurion Fluorescent ruthenium compounds for detecting calcium binding proteins
EP3753481B1 (en) 2006-10-24 2024-07-17 Ascensia Diabetes Care Holdings AG Transient decay amperometry device
GB0711849D0 (en) 2007-06-19 2007-07-25 Oxford Biosensors Ltd Redox Mediators
WO2009076302A1 (en) 2007-12-10 2009-06-18 Bayer Healthcare Llc Control markers for auto-detection of control solution and methods of use
CA2740900C (en) 2008-11-03 2019-09-24 Alethia Biotherapeutics Inc. Antibodies that specifically block the biological activity of a tumor antigen
SI3173427T1 (sl) 2011-03-31 2019-08-30 ADC Therapeutics SA, Protitelesa proti antigenu 1, povezanemu z ledvicami, in antigen vezavni fragmenti le-tega
KR102102239B1 (ko) 2012-01-09 2020-04-21 에이디씨 테라퓨틱스 에스에이 유방암을 치료하기 위한 방법
CN107810420B (zh) 2015-06-25 2020-08-14 豪夫迈·罗氏有限公司 用于测定抗体或配体结合和功能的基于细胞的测定
EP3559666A1 (en) 2016-12-21 2019-10-30 H. Hoffnabb-La Roche Ag Assay for determining antibody or ligand binding and function
EP3700912B1 (en) * 2017-10-25 2022-09-14 Merck Patent GmbH Aromatic amino siloxane functionalized materials for use in capping porous dielectrics

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL49685A (en) * 1976-05-31 1978-10-31 Technion Res & Dev Foundation Specific binding assay method for determining the concentration of materials and reagent means therefor
US4283382A (en) * 1977-12-28 1981-08-11 Eastman Kodak Company Fluorescent labels comprising rare earth chelates
SE428332B (sv) * 1979-03-08 1983-06-20 Wallac Oy Forfarande for fluorescensspektroskopisk bestemning av biologiskt aktivt emne, sasom hapten, antikropp eller antigen
US4372745A (en) * 1979-12-19 1983-02-08 Electro-Nucleonics, Inc. Chemical luminescence amplification substrate system for immunochemistry involving microencapsulated fluorescer
US4293310A (en) * 1980-03-14 1981-10-06 University Of Pittsburgh Photoelectrochemical immunoassay
US4341757A (en) * 1980-09-02 1982-07-27 Nutrition 21 Stable isotopic immunoassay method employing non-radioactive selenium label
SE454115B (sv) * 1982-09-13 1988-03-28 Wallac Oy Homogenfasanalys med lantanidkelat som merksubstans
US5238808A (en) * 1984-10-31 1993-08-24 Igen, Inc. Luminescent metal chelate labels and means for detection

Also Published As

Publication number Publication date
EP0178450A3 (en) 1987-08-05
DK365785D0 (da) 1985-08-12
NO163694C (no) 1990-07-04
US4745076A (en) 1988-05-17
DE3582549D1 (de) 1991-05-23
EP0178450A2 (de) 1986-04-23
DK365785A (da) 1986-03-18
NO853635L (no) 1986-03-18
JPS6173066A (ja) 1986-04-15
ES8705634A1 (es) 1987-05-01
AU4733485A (en) 1986-03-27
EP0178450B1 (de) 1991-04-17
NZ213420A (en) 1990-01-29
NO163694B (no) 1990-03-26
JPH0690201B2 (ja) 1994-11-14
AU586831B2 (en) 1989-07-27
CA1261744A (en) 1989-09-26

Similar Documents

Publication Publication Date Title
ES547019A0 (es) Un procedimiento para la preparacion de un reactivo de inmunoensayo.
ES545464A0 (es) Un procedimiento para la preparacion de tetrahidroftalimidas.
ES540705A0 (es) Un procedimiento para la preparacion de 17b-carbamoil-n-monosustituido -o 17b-acil-4-aza-5-alfa-androstien-3-onas.
ES551249A0 (es) Un procedimiento para la preparacion de peptidilaminodioles.
ES527963A0 (es) Un procedimiento de inmunoensayo
ES555834A0 (es) Un procedimiento para la preparacion de nuevas piranopiridinas.
ES544524A0 (es) Un procedimiento para la preparacion de acidos indol-2-alcanoicos.
ES556738A0 (es) Un procedimiento para la preparacion de nuevos piridazinaminas.
ES530486A0 (es) Un procedimiento para la preparacion de un alquil-fenol.
ES554983A0 (es) Un procedimiento para la preparacion de silileteres.
ES539822A0 (es) Procedimiento para la preparacion de pirazolopiridinas.
ES540609A0 (es) Un procedimiento para la preparacion de pirazolo piridinas.
ES546872A0 (es) Un procedimiento para la preparacion de aminoalcoxibenzopiranonas.
ES544521A0 (es) Un procedimiento para la preparacion de triazolobenzodiazefinas.
ES540610A0 (es) Un procedimiento para la preparacion de pirazolopiridinas.
ES541781A0 (es) Un procedimiento para la preparacion de nuevos benzotiopenos.
ES550504A0 (es) Un procedimiento para la preparacion de derivados de podofilotoxina.
ES555369A0 (es) Un procedimiento para la preparacion de un polialquenoilisocianato.
ES524460A0 (es) Un metodo de inmunoensayo.
ES554661A0 (es) Un procedimiento para la preparacion de un hidralizado proteico.
ES553283A0 (es) Un procedimiento para la preparacion de 2-amino-6-cloropurina.
ES547205A0 (es) Un procedimiento para la preparacion de nuevas quinazolindionas.
ES555723A0 (es) Un procedimiento para la preparacion de tetrahidroimidazoquinazolinonas.
ES541055A0 (es) Un procedimiento para la preparacion de un concentrado emulsionable.
ES555298A0 (es) Un procedimiento para la preparacion de nuevos esteroides 11-b-sustituidos.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19991102